Vitamin D receptor genomic signaling (VDR)

Category: receptor_pharmacology

Overview

The vitamin D receptor (VDR, NR1I1) is a steroid nuclear receptor activated by 1,25-(OH)₂-vitamin D₃ (calcitriol). 1α-hydroxylation in the kidney (CYP27B1) converts 25-OH-D₃ → 1,25-(OH)₂-D₃; extra-renal 1α-hydroxylation in macrophages, keratinocytes, and other tissues enables autocrine/paracrine VDR signaling. Genomic mechanism: calcitriol binds VDR → VDR-RXR heterodimer → binds VDREs in target gene promoters → coactivator recruitment (DRIP/Mediator, SRC-1, p300) → transcription. Canonical mineral-homeostasis targets: intestinal CaBP-9k + TRPV6 → Ca²⁺ absorption; CYP24A1 → calcitriol catabolism (feedback); renal Ca²⁺ reabsorption; bone osteoblast RANKL → osteoclastogenesis. Pleiotropic non-classical targets: keratinocyte differentiation (calcipotriene for psoriasis); innate immunity (cathelicidin/LL-37 in monocytes — TB defense); adaptive immunity (T-reg induction, Th1/Th17 suppression — autoimmunity modulation); insulin secretion (pancreatic β-cell); cardiovascular (RAAS suppression — VDR-knockout mice have ↑RAAS). Non-genomic / membrane-VDR effects: rapid Ca²⁺/cAMP responses (membrane-associated rapid response steroid binding protein). Therapeutics: cholecalciferol (D₃) + ergocalciferol (D₂) — substrate replacement; calcitriol — direct VDR agonist (renal failure, hypocalcemia); paricalcitol + doxercalciferol — selective VDR analogs (less hypercalcemic); calcipotriene/calcipotriol — topical psoriasis. Cross-links: vitamin d metabolism (upstream synthesis + activation), calcium phosphate pth axis (mineral homeostasis), bone remodeling rank rankl (RANKL induction).

Organ Systems

Pathway Steps

  1. 7-dehydrocholesterol (skin) + UVB → previtamin D₃ → cholecalciferol (D₃) — via photolysis; spontaneous thermal isomerization. Vitamin D synthesis starts in skin: UVB photolyzes 7-dehydrocholesterol to previtamin D₃, which thermally isomerizes to cholecalciferol (D₃). Because this step is light-driven, latitude, season, skin pigmentation, and sunscreen all limit it — the basis of widespread vitamin-D insufficiency.
  2. D₃ (skin) / D₂ (diet) → 25-OH-D (storage form) — via liver CYP2R1 (+ CYP27A1 minor). Whether from skin (D₃) or diet (D₂/D₃), vitamin D is first hydroxylated in the liver (CYP2R1) to 25-hydroxyvitamin D. This circulating 25-OH-D is the long-lived storage form and the metabolite measured clinically to assess vitamin-D status — it is not yet the active hormone.
  3. 25-OH-D → 1,25-(OH)₂-D (calcitriol — active) — via kidney CYP27B1 (rate-limiting); upregulated by PTH, ↓Pi; downregulated by FGF23, calcitriol itself. The activating step is renal 1α-hydroxylation (CYP27B1) of 25-OH-D to 1,25-(OH)₂-D (calcitriol). It is tightly regulated by PTH, phosphate, and FGF23 — making the kidney the gatekeeper that sets active-hormone levels, and the reason renal failure causes calcitriol deficiency.
  4. calcitriol + VDR (cytoplasm) → VDR-RXR heterodimer on VDRE — via coactivator recruitment (DRIP/Mediator, SRC-1, p300). Calcitriol diffuses into cells and binds the vitamin D receptor, a nuclear receptor that heterodimerizes with RXR and docks on vitamin D response elements (VDREs). As a ligand-activated transcription factor, VDR exchanges corepressors for coactivators — the genomic basis for vitamin D’s pleiotropic effects.
  5. VDR-RXR on VDRE (intestine) → TRPV6 + calbindin-D9k transcription — via → active Ca²⁺ absorption. In intestine, VDR-RXR induces the calcium-absorption machinery — the apical channel TRPV6 and the cytosolic shuttle calbindin-D9k — driving active transcellular calcium uptake. This is the central calcium-homeostatic action and why severe deficiency causes rickets/osteomalacia.
  6. VDR-RXR on VDRE (bone) → RANKL induction (osteoblasts) — via → osteoclastogenesis when serum Ca²⁺ low. In bone, calcitriol induces RANKL on osteoblasts, which drives osteoclast differentiation and bone resorption to mobilize calcium when needed. So vitamin D both absorbs dietary calcium and, paradoxically, can liberate skeletal calcium — its net skeletal effect depends on calcium supply.
  7. VDR-RXR (macrophages) → cathelicidin / LL-37 transcription — via innate antimicrobial defense — TB association. Beyond mineral metabolism, VDR in macrophages induces the antimicrobial peptide cathelicidin (LL-37) — a key innate-immune output linking vitamin-D status to host defense (notably against M. tuberculosis). This is a major arm of vitamin D’s non-classical, immune-pleiotropic actions.
  8. VDR-RXR → CYP24A1 induction (feedback) — via calcitriol → 24,25-(OH)₂-D inactivation. Calcitriol limits its own signal by inducing CYP24A1, the 24-hydroxylase that catabolizes both 25-OH-D and calcitriol to inactive metabolites — a negative-feedback brake against vitamin-D toxicity. Loss-of-function CYP24A1 mutations cause infantile hypercalcemia.

Known Modulators

References